Debit Insurance (Street-Sold Policies)

Debit Insurance (Street-Sold Policies), also called streetsurance, is inexpensive coverage sold door to door to low-income customers. Its modest premiums and regular collections make it accessible, but the practice becomes especially consequential when insurers deny claims and count on policyholders not to seek legal help. The contrast between small payments and large corporate resources turns a basic insurance product into a test of who can enforce a promise.

Definition and Collection

As Max Leuberg explains to Rudy Baylor, agents sell the policies directly to customers and return about once a week to collect premiums. They record each payment as a debit in the policyholder’s payment book. This recurring, face-to-face system gives the product its everyday character: coverage is bought in small increments from an agent who comes to the customer, rather than through a more formal, lawyerly process.

The customers targeted by this market are people with limited incomes, whom Leuberg describes as often unfamiliar with the law and apprehensive about lawyers and the legal system. The affordability that makes these policies attractive does not ensure that a policyholder can readily obtain its benefits. When a claim is denied, customers may have neither the resources nor the knowledge needed to contest the decision.

Denials and the Economics of Enforcement

Leuberg says insurers routinely turn down claims, offering different reasons for refusing payment. He characterizes the reasons as readily devised, while stressing that relatively few bad-faith denials lead to lawsuits. He cites studies suggesting that about one in thirty reaches court. In another account of the same economic pressure, Cooper Jackson says insurers count on only about one in twenty-five claimants consulting a lawyer. The estimates differ, but both point to the same vulnerability: an insurer can benefit when most policyholders accept a denial rather than challenge it.

The difficulty is not simply whether a claim is covered. Leuberg describes the imbalance between an individual’s legitimate medical expenses and an insurer’s resources: a company worth hundreds of millions may refuse a relatively small covered bill, while jurors may award the bill itself and only a modest amount in punitive damages. In Tennessee, he says, conservative juries and low per-capita income make it particularly difficult to secure a substantial verdict. The result can leave a company facing little financial consequence for refusing a claim, even when the policyholder’s need is serious.

The Claims Process and Section U

Cooper Jackson describes a process that can make delay itself a means of discouraging claims. A claims handler first denies the claim, then requests five years of medical records. The customer receives another denial, this time pending further review. The file moves to underwriting, which instructs claims not to pay until it hears further; correspondence and memos pass between departments while disputes over policy language accumulate.

Although claims and underwriting employees work for the same insurer, Jackson says they may know little about what the other department is doing. The customer, meanwhile, receives communications from both. Most people give up before the process ends. Jackson’s account gains particular force when Rudy Baylor examines the claims and underwriting manuals: each contains a Section U missing from the copies produced in discovery. Read together, the sections direct the departments to deny a claim pending review and then pass it to the other department with instructions not to pay. The promised further notice never arrives. The manuals also describe how to document the steps, creating a paper trail that could make the denial appear carefully reviewed.

Great Benefit and the Stakes of the Case

The Black family’s dispute shows how this business logic can extend beyond individual claims. Jackie Lemancyzk testifies that Great Benefit adopted a twelve-month policy beginning January 1, 1991: claims over $1,000 were initially denied regardless of their merits, while some smaller claims were also ultimately rejected when the company could find an arguable reason. According to her testimony, the policy was expected to save money after the cost of quick settlements, and it produced about $40 million in additional profit.

The Black claim was initially denied under that policy. When the file identified Donny Ray Black’s acute leukemia, Lemancyzk says, the claim received special scrutiny; company personnel knew that the policy covered bone marrow transplants and that Donny Ray’s illness was terminal without one. Her account connects a broad denial strategy to an individual consequence: the company was weighing the chance that a claimant would not obtain a lawyer against the cost of paying a large claim.

Litigation and Significance

In Rudy Baylor’s closing argument, the company’s finances become part of the question of deterrence. He puts Great Benefit’s available cash, reserves, and undistributed surplus at $475 million, alongside an admitted net worth of $450 million, and argues that a punitive award must be large enough to matter to a corporation of that scale. The figures sharpen the contrast already built into the street-insurance system: an affordable policy can be essential to a household, while a disputed claim may be only one item in a powerful company’s calculations.

The concept therefore links the mechanics of selling insurance to the practical limits of legal redress. Regular premium collection makes coverage a familiar part of customers’ lives; fragmented review, repeated denials, and the cost of hiring a lawyer can make the promised protection difficult to claim. In the Black case, exposing the company’s internal procedures and the 1991 denial policy turns a dispute over one family’s benefits into a challenge to the incentives behind mass claim rejection.